RE:RE:RE:RE:RE:Any more suckers selling at the bottom?
the Newbie past 4 yrs complaints... I understand. This is what a startup is. They had to make proof of concept for their IP, jump through regulatory and covid hurdles. When a company goes from development to product on shelves, this is a radical change to a company. They appear to have proved their IP and it's value, could be a continuous growth from here. Timelines and communication are an issue that must be resolved, but, they have breached some of the largest hurdles for any startup. Also, most of the cannabis industry has been built on dilution and acquisitions that may have no value of any kind. This company, is limiting dilution, not promoting absurd useless acquisitions...just straight focus to their IP and related products/partners. Clarity, communication, certainty is unfortunate. When a company developing research IP can go from 70k revenue to millions in orders and partnerships. That is insane and very valuable. They are not buying companies with share dilution, they are building partnerships based on IP. They continue to follow through along this process it could just be a license to print money that they have spend years to earn.